arrow
M

Mirta Peralta

university of buenos aires hospital
H指数:13
被引数:558

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
2023-07-017
OAAI
Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections
2023-02-236
PRE
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

自身免疫性肝炎患者的SARS-CoV-2疫苗接种和严重新型冠状病毒肺炎结局的风险

2022-10-0111
OA
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome
2022-06-2367
OA
Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
2022-03-0130
OAAI
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
2021-12-1330
OA
Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
2021-11-0118
OAAI
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
2021-06-1853
OA
Serious liver injury induced by Nimesulide: an international collaborative study
2021-03-246
OAAI
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
2021-03-0129
OAAI
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
2020-10-0150
PREAI
Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort
2020-08-136
PREAI
Serious liver injury induced by nimesulide: An international collaboration reporting 57 cases
2019-04-010
PREAI
Effectiveness and safety of original and generic sofosbuvir for the treatment of chronic hepatitis C: A real world study
2018-02-1519
PREAI
Ombitasvir/paritaprevir/ritonavir/dasabuvir ± ribavirin is safe and effective in HCV-infected patients in a real-life cohort from Latin America
2017-06-0612
OAAI